Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maxasome PLUS
- Development stage
- Preclinical
- Lead developer
- Nexel
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intranasal, Oral, Sublingual
01
Overview
Maxasome PLUS is an advanced, next-generation exosome-based nutraceutical and wellness therapeutic developed by NexTel Medical Corp. (formerly Exousia Pro, Inc.). It is an enhanced formulation of the company's flagship Maxasome product, featuring additional bioactive compounds designed to support immunity, longevity, and cellular protection. The product is powered by 100% pure exosome-like nanoparticles (ELNs) derived from the Yellow Oyster Mushroom (*Pleurotus citrinopileatus*), which shield the bioactive payload—including ergothioneine, beta-glucans, terpenoids, phenolic compounds, and vitamin D2—from digestive degradation to ensure high bioavailability. Maxasome PLUS is currently being evaluated for its anti-aging properties in collaboration with Baylor University and is also being investigated for therapeutic applications in traumatic brain injury (TBI).
- Brand names
- Maxasome PLUS
- Other names
- Maxasome Plus
02
Targets
CLEC7A (Dectin-1)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Maxasome PLUS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maxasome PLUS.